Catalyst Pharmaceuticals, Inc.
US ˙ NASDAQCM ˙ US14888U1016 ˙ Medical Devices
DIESES SYMBOL IST NICHT MEHR AKTIV

SecurityCPRX / Catalyst Pharmaceuticals, Inc.
InstitutionRYMKX - Russell 2000 1.5x Strategy Fund Class H
Latest Disclosed Ownership158 shares
Latest Disclosed Value $ 3,912
RYMKX - Russell 2000 1.5x Strategy Fund Class H ownership in CPRX / Catalyst Pharmaceuticals, Inc.

On June 1, 2026 - RYMKX - Russell 2000 1.5x Strategy Fund Class H filed a NPORT-P form disclosing ownership of 158 shares of Catalyst Pharmaceuticals, Inc. (US:CPRX) valued at $3,912 USD as of March 31, 2026. The entity filed a previous NPORT-P on March 2, 2026 disclosing 158 shares of Catalyst Pharmaceuticals, Inc.. This represents a change in shares of 0.00% during the quarter. The current value of the position is $4,975 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-06-01 2026-03-31 NP Catalyst Pharmaceuticals Inc. COM EC US14888U1016 158 0 0.00 4 0.00 0.0657
2026-03-02 2025-12-31 NP Catalyst Pharmaceuticals EC US14888U1016 158 -3 -1.86 4 0.00 0.0437
2025-12-01 2025-09-30 NP Catalyst Pharmaceuticals EC US14888U1016 161 -2 -1.23 3 0.00 0.0475
2025-08-27 2025-06-30 NP Catalyst Pharmaceuticals EC US14888U1016 163 9 5.84 4 0.00 0.0604
2025-05-29 2025-03-31 NP Catalyst Pharmaceuticals EC US14888U1016 154 -21 -12.00 4 0.00 0.0718
2025-03-03 2024-12-31 NP Catalyst Pharmaceuticals EC US14888U1016 175 0 0.00 4 0.00 0.0464
2024-11-29 2024-09-30 NP Catalyst Pharmaceuticals EC US14888U1016 175 -8 -4.37 3 50.00 0.0535
2024-08-29 2024-06-30 NP Catalyst Pharmaceuticals EC US14888U1016 183 15 8.93 3 0.00 0.0474
2024-05-30 2024-03-31 NP Catalyst Pharmaceuticals EC US14888U1016 168 17 11.26 3 0.00 0.0376
2024-02-29 2023-12-31 NP Catalyst Pharmaceuticals EC US14888U1016 151 -16 -9.58 3 100.00 0.0368
2023-11-29 2023-09-30 NP Catalyst Pharmaceuticals EC US14888U1016 167 0 0.00 2 -50.00 0.0341
2023-08-28 2023-06-30 NP Catalyst Pharmaceuticals EC US14888U1016 167 1 0.60 2 0.00 0.0331
2023-05-30 2023-03-31 NP Catalyst Pharmaceuticals EC US14888U1016 166 0 0.00 3 -33.33 0.0442
2023-02-28 2022-12-31 NP Catalyst Pharmaceuticals EC US14888U1016 166 -39 -19.02 3 50.00 0.0511
2022-11-29 2022-09-30 NP Catalyst Pharmaceuticals EC US14888U1016 205 0 0.00 3 100.00 0.0372
2022-08-29 2022-06-30 NP Catalyst Pharmaceuticals EC US14888U1016 205 -38 -15.64 1 -50.00 0.0202
2022-05-26 2022-03-31 NP Catalyst Pharmaceuticals EC US14888U1016 243 145 147.96 2 0.0202
2022-02-28 2021-12-31 NP Catalyst Pharmaceuticals EC US14888U1016 98 98 1 0.0067
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.